In the BioHarmony Drug Report Database

"Preview" Icon

Ataluren

Translarna (ataluren) is a small molecule pharmaceutical. Ataluren was first approved as Translarna on 2014-07-31. It has been approved in Europe to treat duchenne muscular dystrophy.

 

Trade Name

 

Translarna
 

Common Name

 

ataluren
 

ChEMBL ID

 

CHEMBL256997
 

Indication

 

duchenne muscular dystrophy
 

Drug Class

 

Inducers of ribossomal readthrough of nonsense mutation mRNA stop codons

Image (chem structure or protein)

Ataluren structure rendering